Hidradenitis Suppurativa Treatment, Biologics & Breakthroughs
Failed to add items
Add to Cart failed.
Add to Wish List failed.
Remove from wishlist failed.
Adding to library failed
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
What is Hidradenitis Suppurativa (HS), and how is it treated? In this episode of the Science of Skin podcast, dermatologist Dr. Ted Lain is joined by HS specialist Dr. Steve Daveluy to break down everything you need to know about this chronic inflammatory skin disease — from early diagnosis to cutting-edge treatments.
In this episode, we cover:
- What is Hidradenitis Suppurativa (HS) and who does it affect?
- Why pain is the #1 reason HS patients seek medical care
- How shame and stigma impact HS patients — and why HS is never the patient's fault
- Early HS treatment options: antimicrobial washes, topical antibiotics, and more
- The role of biologics in managing moderate-to-severe HS
- Emerging HS treatments: JAK inhibitors, nanobodies, and drugs in the pipeline
- Understanding HS pathogenesis and the immune pathways involved
- Why a multifactorial, personalized treatment approach is essential for HS management
Whether you're a dermatologist, healthcare provider, or someone personally affected by Hidradenitis Suppurativa, this episode offers expert insight into the latest research, treatment strategies, and the future of HS care.
🎙️ Subscribe to the Science of Skin podcast for the latest in dermatology, skincare science, and clinical breakthroughs.
DISCLAIMER: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.
See omnystudio.com/listener for privacy information.